Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study-Reference-Cited by-同舟云学术

Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study

Published:2001-11-15 Issue:10 Volume:98 Page:3174-3174
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Bacigalupo Andrea¹,Lamparelli Teresa¹,Gualandi Francesca¹,Bregante Stefania¹,Raiola AnnaMaria¹,di Grazia Carmen¹,Dominietto Alida¹,Romagnani Chiara¹,Occhini Domenico¹,Frassoni Francesco¹,van Lint Maria Teresa¹

Affiliation:

1. Correspondence: A. Bacigalupo, Divisione Ematologia 2 (PAD 5/II), Ospedale San Martino, Largo Rosanna Benzi, 16132 Genova, Italy; e-mail:

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/98/10/3174/1678683/h8220103172b.pdf

Reference2 articles.

1. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia.;Bacigalupo;Blood.,1991

2. Graft versus host disease prophylaxis with low dose cyclosporine reduces the risk of relapse in children with acute leukemia given HLA identical sibling bone marrow transplantation: results of a randomized trial.;Locatelli;Blood.,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation;Journal of Clinical Oncology;2021-02-10

2. Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application;Bone Marrow Transplantation;2019-05-14

3. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis;Biology of Blood and Marrow Transplantation;2018-03

4. In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review;Bone Marrow Transplantation;2017-07-10

5. Relapse assessment following allogeneic SCT in patients with MDS and AML;Annals of Hematology;2014-03-27